Clinical Trial Update: Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Betta Pharmaceuticals compares sequential and maintenance icotinib plus chemotherapy with icotinib maintenance after chemotherapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: EGFR Positive Non-small Cell Lung Cancer, Adenocarcinoma | Phase 4 | Status: UNKNOWN